As anticipated, given the disappointing year end trading update in January, Deltex had a very challenging 2014, with surgical probe revenues down 17% to £4.56m and overall revenues down 9% to £6.51m. Against the background of the increased investment to drive US growth, this resulted in an increase in the underlying cash loss from £0.29m to £1.68m and an increase in the reported loss before tax from £2.22m to £3.10m, although we note that this was better th ....